首頁 > 市場調查報告書 > 製藥

眼科藥物

市場調查報告書

商品編碼

1812414

水痘角膜病變 (BK) 市場：按治療類型、疾病類型、年齡層、分銷管道、最終用戶和地區分類

Bullous Keratopathy Market, By Treatment Type, By Disease Type, By Age Group, By Distribution Channel, By End User, By Geography

出版日期: 2025年08月14日 | 出版商:

Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

水痘角膜病變 (BK) 市場規模預計在 2025 年達到 16.2 億美元，預計到 2032 年將達到 29.2 億美元，2025 年至 2032 年的複合年成長率為 8.8%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	16.2億美元
效能數據	2020年至2024年	預測期	2020年至2024年
預測期：2025-2032年複合年成長率：	8.80%	2032年的價值預測	29.2億美元

水痘角膜病變（BK）是一種重要的角膜疾病，其特徵是上皮和基質水腫的形成，導致疼痛性水痘的形成和嚴重的視力障礙。

這種退化性疾病主要影響角膜內皮細胞，導致泵血功能受損和角膜層內液體積聚。全球水痘角膜病變 (BK) 市場涵蓋各種治療性介入、診斷技術和手術解決方案，旨在治療這種令人衰弱的眼科疾病。其主要原因包括福克斯角膜內皮營養不良症、白內障手術後的水痘大泡性角膜病變、外傷引起的內皮損傷。

治療方法包括使用高滲透壓鹽水和OK繃隱形眼鏡的保守治療，以及先進的外科手術干預，如 Descemet 膜剝離自動內皮角膜移植術 (DSAEK)、Descemet 膜內皮角膜移植術 (DMEK) 和穿透性角膜移植術。動態受到與老齡化相關的角膜疾病盛行率不斷上升、白內障手術數量不斷增加、角膜移植技術的進步以及對可用治療方案的認知不斷提高的影響。

醫療保健提供者、製藥公司、醫療設備製造商和研究機構正在透過創新的治療方案、改進的手術器材和增強的患者照護通訊協定積極促進市場發展，推動這個專業眼科領域的持續成長。

市場動態

全球水痘角膜病變 (BK) 市場主要受多種重要因素驅動，這些因素推動市場擴張和創新。全球人口老化是市場成長的主要動力，因為水痘角膜病變 (BK) 主要影響老年人，而福克斯角膜內皮營養不良症和老齡化性角膜病變的盛行率不斷上升，對有效治療方案的需求巨大。

在全球範圍內，白內障手術數量不斷增加，雖然總體上取得了成功，但由於偶爾出現的假性白內障水痘角膜病變 (BK)併發症，導致越來越多的患者需要專科護理。角膜移植技術的進步，尤其是DSAEK和DMEK等選擇性內皮角膜移植技術的發展，徹底改變了治療效果，與傳統的穿透性角膜移植相比，其恢復時間更短、排斥反應更少、視力恢復更好。

然而，該市場面臨許多限制因素，包括角膜組織捐贈來源有限，導致治療延誤嚴重，並限制了市場成長潛力。高昂的治療費用（包括手術介入、專科藥物和術後照護）限制了治療的可近性，尤其是在醫療預算有限的新興經濟體。此外，複雜的手術過程需要高技能的角膜專家，這導致治療的可及性和品質在不同地區存在差異。

然而，巨大的商業機會仍然存在，因為捐贈者短缺的挑戰可以透過組織工程解決方案、人工角膜替代品和幹細胞療法等新型再生醫學方法來解決。新興市場的醫療基礎設施建設、醫療旅遊業的蓬勃發展以及角膜疾病保險覆蓋範圍的擴大，都為該領域帶來了豐厚的擴張機會。此外，針對內皮功能障礙的藥物介入和創新藥物傳遞系統的持續研究，有可能創造新的治療模式，並顯著改變市場格局。

本次調查的主要特點

本報告對全球水痘角膜病變 (BK) 市場進行了詳細分析，提供了預測期 (2025-2032) 的市場規模（十億美元）和年複合成長率（CAGR%），以 2024 年為基準年。
它還強調了各個領域的潛在商機，並說明了針對該市場的引人注目的投資提案。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。
它根據公司亮點、產品系列、關鍵亮點、財務業績和策略等參數，對全球水痘角化病市場的主要企業進行了概述。
本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、新興車型、市場擴張和行銷策略做出明智的決策。
全球水痘角膜病變 (BK) 市場報告針對該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員可以透過用於分析全球水痘角化病市場的各種策略矩陣來更輕鬆地做出決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 1.62 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	8.80%	2032 Value Projection:	USD 2.92 Bn

This degenerative condition primarily affects the corneal endothelium, resulting in compromised pump function and subsequent fluid accumulation within corneal layers. The global bullous keratopathy market encompasses various therapeutic interventions, diagnostic technologies, and surgical solutions designed to address this debilitating ocular condition. Primary etiologies include Fuchs' endothelial dystrophy, pseudophakic bullous keratopathy following cataract surgery, and trauma-induced endothelial damage.

Treatment modalities range from conservative management using hypertonic saline solutions and bandage contact lenses to advanced surgical interventions including Descemet's stripping automated endothelial keratoplasty (DSAEK), Descemet's membrane endothelial keratoplasty (DMEK), and penetrating keratoplasty. The market dynamics are influenced by increasing prevalence of age-related corneal disorders, rising cataract surgeries, technological advancements in corneal transplantation techniques, and growing awareness about available treatment options.

Healthcare providers, pharmaceutical companies, medical device manufacturers, and research institutions actively contribute to market development through innovative therapeutic solutions, improved surgical instruments, and enhanced patient care protocols, driving sustained growth in this specialized ophthalmic segment.

Market Dynamics

The global bullous keratopathy market is primarily driven by several compelling factors that collectively propel market expansion and innovation. The aging global population significantly contributes to market growth, as bullous keratopathy predominantly affects elderly individuals, with increasing incidence of Fuchs' endothelial dystrophy and age-related corneal disorders creating substantial demand for effective treatment solutions.

Rising volumes of cataract surgeries worldwide, while generally successful, occasionally result in pseudophakic bullous keratopathy complications, thereby expanding the patient pool requiring specialized interventions. Technological advancements in corneal transplantation techniques, particularly the development of selective endothelial keratoplasty procedures like DSAEK and DMEK, have revolutionized treatment outcomes, offering faster recovery times, reduced rejection rates, and improved visual rehabilitation compared to traditional penetrating keratoplasty methods.

However, the market faces significant restraints including limited availability of donor corneal tissue, which creates substantial treatment delays and restricts market growth potential. High treatment costs associated with surgical interventions, specialized medications, and post-operative care limit accessibility, particularly in developing economies with constrained healthcare budgets. Additionally, the complexity of surgical procedures requires highly skilled corneal specialists, creating geographic disparities in treatment availability and quality.

Nevertheless, substantial opportunities exist through emerging regenerative medicine approaches, including tissue engineering solutions, artificial corneal substitutes, and stem cell therapies that could potentially address donor shortage challenges. Increasing healthcare infrastructure development in emerging markets, growing medical tourism, and enhanced insurance coverage for corneal disorders present lucrative expansion opportunities. Furthermore, ongoing research into pharmacological interventions for endothelial dysfunction and innovative drug delivery systems could create new therapeutic paradigms, transforming the market landscape significantly.

Key Features of the Study

This report provides in-depth analysis of the global bullous keratopathy market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global bullous keratopathy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Alcon Inc., Bausch + Lomb, Carl Zeiss Meditec AG, Johnson and Johnson Vision, CorneaGen Inc., Glaukos Corporation, HumanOptics AG, Aurolab, Gebauer Medizintechnik GmbH, Mediphacos Ltda, Nidek Co., Ltd., Presbia PLC, Rayner Surgical Group Ltd., and Ziemer Ophthalmic Systems AG.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global bullous keratopathy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bullous keratopathy market

Market Segmentation

Treatment Type Insights (Revenue, USD Bn, 2020 - 2032)
- Non-Surgical Treatments
- Hyperosmotic agents (topical hypertonic saline)
- Anti-Glaucoma Drugs (e.g., beta-blockers, alpha agonists)
- Antibiotics
- Lubricating eye drops
- Therapeutic contact lenses
- Others (Steroids, NSAIDs, etc.)
- Surgical Treatments
- Corneal transplantation (penetrating keratoplasty, endothelial keratoplasty)
- Amniotic membrane grafting
- Anterior stromal puncture
- Basement membrane polishing
- Others (Annular keratotomy, etc.)
Disease Type Insights (Revenue, USD Bn, 2020 - 2032)
- Pseudophakic bullous keratopathy (after cataract surgery)
- Fuchs' endothelial dystrophy
- Glaucoma-related bullous keratopathy
- Infectious keratitis-related bullous keratopathy
- Others
Age Group Insights (Revenue, USD Bn, 2020 - 2032)
- Adult
- Pediatric
- Geriatric
Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
- Hospital pharmacies
- Retail pharmacies
- Online pharmacies
End User Insights (Revenue, USD Bn, 2020 - 2032)
- Hospitals
- Ophthalmology clinics
- Ambulatory surgery centers (ASC)
- Others (Academic and research institutes)
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Alcon Inc.
- Bausch + Lomb
- Carl Zeiss Meditec AG
- Johnson and Johnson Vision
- CorneaGen Inc.
- Glaukos Corporation
- HumanOptics AG
- Aurolab
- Gebauer Medizintechnik GmbH
- Mediphacos Ltda
- Nidek Co., Ltd.
- Presbia PLC
- Rayner Surgical Group Ltd.
- Ziemer Ophthalmic Systems AG

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Bullous Keratopathy Market, By Treatment Type
- Global Bullous Keratopathy Market, By Disease Type
- Global Bullous Keratopathy Market, By Age Group
- Global Bullous Keratopathy Market, By Distribution Channel
- Global Bullous Keratopathy Market, By End User
- Global Bullous Keratopathy Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Bullous Keratopathy Market, By Treatment Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Non-Surgical Treatments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  - Hyperosmotic agents (topical hypertonic saline)
  - Anti-Glaucoma Drugs (e.g., beta-blockers, alpha agonists)
  - Antibiotics
  - Lubricating eye drops
  - Therapeutic contact lenses
  - Others (Steroids, NSAIDs, etc.)
Surgical Treatments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  - Corneal transplantation (penetrating keratoplasty, endothelial keratoplasty)
  - Amniotic membrane grafting
  - Anterior stromal puncture
  - Basement membrane polishing
  - Others (Annular keratotomy, etc.)

5. Global Bullous Keratopathy Market, By Disease Type, 2025-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Pseudophakic bullous keratopathy (after cataract surgery)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Fuchs' endothelial dystrophy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Glaucoma-related bullous keratopathy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Infectious keratitis-related bullous keratopathy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Bullous Keratopathy Market, By Age Group, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Geriatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Bullous Keratopathy Market, By Distribution Channel, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospital pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Retail pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Online pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Bullous Keratopathy Market, By End User, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Ophthalmology clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Ambulatory surgery centers (ASC)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others (Academic and research institutes)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Bullous Keratopathy Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Disease Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Disease Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Disease Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Disease Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Disease Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Disease Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

10. Competitive Landscape

Alcon Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bausch + Lomb
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Carl Zeiss Meditec AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Johnson and Johnson Vision
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
CorneaGen Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Glaukos Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
HumanOptics AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Aurolab
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Gebauer Medizintechnik GmbH
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Mediphacos Ltda
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Nidek Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Presbia PLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Rayner Surgical Group Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Ziemer Ophthalmic Systems AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies